Systematic screening for multimorbidities in patients with inflammatory rheumatic diseases enhanced preventive medication use and reduced hospitalisations: an exposed-non-exposed study
Open Access
Abstract
Rational Studies are needed to determine if multimorbidity screening and management reduce the rate of multimorbidity accumulation in patients with chronic inflammatory rheumatic diseases (IRD). Objectives This study evaluates the impact of systematic screening programme on patient care and hospitalisation rates. Methods Patients with IRD who participated in the screening programme (exposed patients) were identified within the French national health database and matched with controls. Two sets of analysis were performed: one with multivariate analysis and a second using a propensity score matching to ensure comparability between exposed patients and controls. The primary endpoint (PE) was a composite score assessing the dispensation of multimorbidity-preventing drugs, including vaccines, lipid-lowering agents, antiosteoporotic medications and antiplatelet drugs, during the year following the index date. Results The first analysis included 286 exposed patients and 858 controls, demonstrating a higher rate of meeting the PE in exposed patients (adjusted OR=1.6 (1.2–2.2), pConclusion Systematic multimorbidity screening in patients with IRD boosted preventive medication use and reduced hospital admissions, justifying time and resource allocation for screening.Keywords
Funding Information
- Pfizer (unconditional financial support)
This publication has 13 references indexed in Scilit:
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesAnnals of the Rheumatic Diseases, 2020
- Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseasesJoint Bone Spine, 2019
- COPD: an overlooked cause of excess mortality in patients with rheumatoid arthritisThe Lancet Respiratory Medicine, 2018
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 updateAnnals of the Rheumatic Diseases, 2017
- Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiativeAnnals of the Rheumatic Diseases, 2016
- Vaccinations in adults with chronic inflammatory joint disease: Immunization schedule and recommendations for patients taking synthetic or biological disease-modifying antirheumatic drugsJoint Bone Spine, 2016
- Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow‐Up: Results From the Nurses’ Health StudyArthritis Care & Research, 2015
- Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid ArthritisArthritis Care & Research, 2014
- Clinical assessment of the long‐term risk of fracture in patients with rheumatoid arthritisArthritis & Rheumatism, 2006
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002